AI-Assisted UWF Lesion-Based Triage System
Diagnostic TestReaders interpret UWF retinal images with lesion-level AI findings and urgent referral recommendations.
NCT Number: NCT07643129
his study evaluates the clinical utility of an artificial intelligence (AI)-assisted lesion-based urgent referral triage system for ultra-widefield (UWF) retinal images.
Unlike disease-classification systems, the AI system identifies predefined vision-threatening retinal findings and generates lesion-level urgent referral recommendations. Participating ophthalmologists will evaluate UWF retinal images under randomized AI-assisted and unassisted conditions.
The primary objective is to determine whether lesion-based AI assistance improves urgent referral triage performance compared with unaided image interpretation.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Ultra-widefield retinal imaging is increasingly used for retinal disease screening and referral triage. Many vision-threatening retinal abnormalities require timely identification and referral to retinal specialists.
The AI system evaluated in this study is designed as a lesion-based triage tool rather than a disease-diagnosis system. The model identifies predefined urgent referral retinal findings and generates referral recommendations based on lesion-level evidence.
Urgent referral findings include:
A total of 600 UWF retinal images acquired using Zeiss and Optos imaging systems will be included.
Participating ophthalmologists will independently evaluate images in randomized AI-assisted and unassisted settings.
The primary objective is to determine whether AI assistance improves lesion-based urgent referral triage accuracy.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Readers interpret UWF retinal images with lesion-level AI findings and urgent referral recommendations.
Readers interpret UWF retinal images without AI assistance.
Time frame: Through study completion, up to 2 months
Proportion of reader referral decisions consistent with expert-adjudicated lesion-based urgent referral classifications.
Time frame: Through study completion, up to 2 months
Sensitivity for correctly classifying non-urgent referral images according to expert-adjudicated lesion-based triage labels.
Time frame: Through study completion, up to 2 months
Specificity for correctly classifying non-urgent referral images according to expert-adjudicated lesion-based triage labels.
Time frame: Through study completion, up to 2 months
Proportion of urgent referral images incorrectly classified as non-urgent referral by readers.
Time frame: Through study completion, up to 2 months
Proportion of non-urgent referral images incorrectly classified as urgent referral by readers.
Time frame: Immediately after image interpretation.
Reader-reported confidence level for referral decisions measured using a 5-point Likert scale, ranging from 1 (very uncertain) to 5 (very confident).
Time frame: Through study completion, up to 2 months
Number and proportion of cases in which AI assistance changed an incorrect referral decision to a correct referral decision.
Contact information is provided by the study sponsor or research team.
Xiamen Ophthalmology Center Affiliated to Xiamen University
Other
Clinical Utility of an Artificial Intelligence-Assisted Lesion-Based Urgent Referral Triage System for Ultra-Widefield Retinal Images: A Prospective Multi-Reader Multi-Case Randomized Reader Study
Acronym: ALERT-UWF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07184255
Eye Diseases, Retinal Detachment
Toronto, Ontario, Canada
View Trial DetailsNCT05538156
Eye Diseases, Proliferative Vitreoretinopathy
View Trial DetailsNCT07731984
Eye Diseases, Retinal Detachment
Sohag, Egypt
View Trial DetailsNCT02423213
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases
Cleveland, Ohio, United States
View Trial Details